Metabolic dysfunction-associated steatotic liver disease (MASLD) is a risk factor for liver cirrhosis, hepatocellular carcinoma, and systemic complications such as cardiovascular diseases, type 2 diabetes mellitus (T2DM), chronic kidney disease or systemic inflammation, etc
Wegovy is an injectable semaglutide at a higher dose, FDA-approved specifically for chronic weight management in adults with obesity or overweight with at least one weight-related condition
Here are some standard approaches: Wash your hands thoroughly with soap and water
A simple approach to the estimation of incidence rate difference
If you want to look as refreshed as you feel this holiday season, Botox and dermal fillers could be your perfect solution
Laboratory tests of liver function are indicated if liver disease is suggested by the history and physical examination